JPS635391B2 - - Google Patents
Info
- Publication number
- JPS635391B2 JPS635391B2 JP54072954A JP7295479A JPS635391B2 JP S635391 B2 JPS635391 B2 JP S635391B2 JP 54072954 A JP54072954 A JP 54072954A JP 7295479 A JP7295479 A JP 7295479A JP S635391 B2 JPS635391 B2 JP S635391B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- compound
- benzyloxy
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7817388A FR2428032A1 (fr) | 1978-06-09 | 1978-06-09 | Nouvelles oxazolidimones, oxazolidinethiones et pyrrolidinones, leur procede de preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5551064A JPS5551064A (en) | 1980-04-14 |
| JPS635391B2 true JPS635391B2 (enExample) | 1988-02-03 |
Family
ID=9209330
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7295479A Granted JPS5551064A (en) | 1978-06-09 | 1979-06-09 | Novel aryloxazolidinone*oxazolidinethione* pyrrolidinone*pyrrolidine and thiazolidinone* their manufacture and their therapeutic application |
| JP6772281A Granted JPS56167666A (en) | 1978-06-09 | 1981-05-07 | N-aryloxazolidinone, pyrrolidinone and their manufacture |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6772281A Granted JPS56167666A (en) | 1978-06-09 | 1981-05-07 | N-aryloxazolidinone, pyrrolidinone and their manufacture |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JPS5551064A (enExample) |
| FR (1) | FR2428032A1 (enExample) |
| ZA (1) | ZA792799B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2458547B2 (fr) * | 1978-06-09 | 1986-05-16 | Delalande Sa | Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique |
| FR2506769A2 (fr) * | 1978-06-09 | 1982-12-03 | Delalande Sa | Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique |
| FR2500450A1 (fr) * | 1981-02-25 | 1982-08-27 | Delalande Sa | Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique |
| FR2528046B1 (fr) * | 1982-06-08 | 1985-06-21 | Delalande Sa | Derives de l'oxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques et reversibles de la monoamine oxydase de type b et leur procede de preparation |
| JPS608277A (ja) * | 1983-06-07 | 1985-01-17 | ザ・デュポン・メルク・ファーマシュウティカル・カンパニー | アミノメチルオキソオキサゾリジニルベンゼン誘導体 |
| CA1302422C (en) * | 1986-09-03 | 1992-06-02 | Margherita Strolin-Benedetti | 5-aminoethyloxazolidin-2-one derivatives, process for the preparation thereofand their therapeutic use |
| FR2603279B1 (fr) * | 1986-09-03 | 1988-12-16 | Rech Ind | Benzyloxy-phenyl-oxazolidinones, procede de preparation et utilisation en therapeutique |
| FR2609029B1 (fr) * | 1986-12-30 | 1989-12-08 | Delalande Sa | Derives 5-aminoethyles de l'oxazolidinone-2, leur procede de preparation et leur application en therapeutique |
| JPWO2007116960A1 (ja) * | 2006-04-06 | 2009-08-20 | 財団法人乙卯研究所 | 炭素環を有するオキサゾリジノン誘導体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1602544A (en) * | 1968-10-29 | 1970-12-21 | Acetylenic 2-oxazolidinones | |
| GB1250538A (enExample) * | 1969-03-18 | 1971-10-20 | ||
| CH618682A5 (enExample) * | 1975-11-07 | 1980-08-15 | Ciba Geigy Ag |
-
1978
- 1978-06-09 FR FR7817388A patent/FR2428032A1/fr active Granted
-
1979
- 1979-06-06 ZA ZA792799A patent/ZA792799B/xx unknown
- 1979-06-09 JP JP7295479A patent/JPS5551064A/ja active Granted
-
1981
- 1981-05-07 JP JP6772281A patent/JPS56167666A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56167666A (en) | 1981-12-23 |
| FR2428032B1 (enExample) | 1981-10-16 |
| ZA792799B (en) | 1980-08-27 |
| JPH039106B2 (enExample) | 1991-02-07 |
| JPS5551064A (en) | 1980-04-14 |
| FR2428032A1 (fr) | 1980-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4657911A (en) | 3-amino quinuclidine derivatives and the application thereof as accelerators of gastro-intestinal motor function | |
| SE446733B (sv) | Nya n-aryloxazolidinoner, oxazolidintioner, pyrrolidinoner, pyrrolidiner och tiazolidinoner och sett att framstella desamma samt kompositioner derav | |
| US20030130509A1 (en) | Process to produce 3-carbon amino alcohol salts | |
| JPH1180139A (ja) | 3−(縮合環置換)フェニル−5β−アミドメチルオキサゾリジン−2−オン類および3−(窒素原子置換)フェニル−5β−アミドメチルオキサゾリジン−2−オン類 | |
| US4517197A (en) | -N-substituted phenyl-5-methoxymethyl-2-oxazolidinones and pharmaceutical compositions containing same | |
| CN108718527A (zh) | 用于制备4-苯基-5-烷氧羰基-2-噻唑-2-基-1,4-二氢嘧啶-6-基]甲基]-3-氧代-5,6,8,8a-四氢-1H-咪唑并[1,5-a]吡嗪-2-基]-甲酸的方法 | |
| GB2357763A (en) | Purification of Citalopram | |
| SK13132002A3 (sk) | Spôsob výroby soli citalopramu, kryštalická báza citalopramu a soli citalopramu a farmaceutický prostriedok s ich obsahom | |
| JP3323420B2 (ja) | ベンズイミダゾール誘導体 | |
| JP7574450B2 (ja) | アミノピリジン系化合物及びその使用 | |
| JPH10504820A (ja) | N−置換されたフェノチアジン類の使用 | |
| JPH02138266A (ja) | 6‐フェニル‐3‐(ピペラジニルアルキル)‐2,4(1h,3h)‐ピリミジンジオン誘導体 | |
| KR102207333B1 (ko) | 4중 연속 고리 화합물의 신규한 제조방법 | |
| EP0511031B1 (fr) | Dérivés d'aryl-3 oxazolidinone, leur procédé de préparation et leur application en thérapeutique | |
| CN1122666C (zh) | 新的2,3-二氢化茚醇化合物,其制备方法和包含它们的药物组合物 | |
| JPH032116A (ja) | ベンゼン誘導体、その調製およびこれを含有する薬学的組成物 | |
| JPS58116434A (ja) | 置換されたフエノキシアルカノ−ルアミン類及びフエノキシアルカノ−ル−シクロアルキルアミン類 | |
| US6538134B2 (en) | 4-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereof | |
| JPS5950671B2 (ja) | フェニルエタノ−ルアミン誘導体およびその製造法 | |
| US4705807A (en) | Amine derivatives | |
| JPS6135165B2 (enExample) | ||
| JPH037280A (ja) | 新規ベンゾチオピラニルアミン | |
| JPS5824575A (ja) | テトラヒドロナフトオキサゾ−ル類 | |
| Matsubara et al. | RECYCLISATION OF 2-OXOTETRAHYDRO-1, 3-OXAZINES ACCOMPANIED BY DECARBOXYLATION: A CONVENIENT SYNTHESIS OF TETRAHYDROPYRIDINE, QUINOLIZIDINE, AND INDOLIZIDINE SKELETONS | |
| KR100467309B1 (ko) | 옥사졸리디논유도체및그의제조방법및항균제조성물 |